Gossamer Bio, Inc.
GOSS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $46 | $32 | $112 | $183 |
| Short-Term Investments | $248 | $264 | $144 | $142 |
| Receivables | $5 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $10 | $10 | $6 | $7 |
| Total Curr. Assets | $310 | $307 | $262 | $332 |
| Property Plant & Equip (Net) | $5 | $5 | $10 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $1 |
| Total NC Assets | $5 | $5 | $11 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $315 | $312 | $272 | $344 |
| Liabilities | – | – | – | – |
| Payables | $2 | $6 | $1 | $3 |
| Short-Term Debt | $1 | $15 | $15 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $17 | $0 | $0 | $0 |
| Other Curr. Liab. | $25 | $31 | $33 | $34 |
| Total Curr. Liab. | $45 | $52 | $49 | $40 |
| LT Debt | $202 | $198 | $211 | $182 |
| Deferred Rev, NC | $39 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $241 | $198 | $211 | $182 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $3 | $6 | $6 |
| Total Liabilities | $286 | $249 | $260 | $222 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,269 | -$1,212 | -$1,032 | -$812 |
| AOCI | $1 | -$0 | -$1 | $0 |
| Other Equity | $1,297 | $1,275 | $1,045 | $933 |
| Total Equity | $29 | $63 | $12 | $121 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $315 | $312 | $272 | $344 |
| Net Debt | $157 | $180 | $114 | $2 |